[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337608-105":59,"doc-detail-337608-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dna-methylation-markers-for-risk-of-metastasis-in-a-cohort-of-men-with-localized-prostate-cancer","DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer","","Accurately identifying life-threatening prostate cancer at diagnosis remains unresolved. This nested case-control study evaluated whether DNA methylation status of selected candidate genes predicts metastasis risk beyond clinical factors in men with untreated localized prostate cancer. Cases developed metastasis within 10 years; controls used density sampling. Ninety-eight candidate genes were examined, with CpG-site and principal-components analyses in conditional logistic regression. Significant associations were found for 27 genes in 215 cases and 404 controls, with partial agreement between methods.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dna-methylation-markers-for-risk-of-metastasis-in-a-cohort-of-men-with-localized-prostate-cancer/337608/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dna-methylation-markers-for-risk-of-metastasis-in-a-cohort-of-men-with-localized-prostate-cancer/337608.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study goal regarding DNA methylation and metastasis?","Question",{"text":112,"@type":113},"To determine whether DNA methylation status of selected candidate genes could predict metastasis risk beyond clinical risk factors in men with untreated localized prostate cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were cases and controls defined in the nested case-control design?",{"text":117,"@type":113},"Cases were men who developed metastasis within 10 years from diagnosis. Controls were selected using density sampling among men diagnosed with localized prostate cancer who did not receive curative treatments.",{"name":119,"@type":110,"acceptedAnswer":120},"How many candidate genes were analyzed and what were the key findings?",{"text":121,"@type":113},"Ninety-eight candidate genes from metastasis- and biology-related functional categories plus 41 pluripotency genes were analyzed. In 215 cases and 404 controls, 27 genes showed statistically significant associations with metastasis risk in at least one analytical approach.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337608,1790806777,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE     \nDNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer  \nTalar S. Habeshian a,b, Kimberly L. Cannavale a, Jeff M. Slezak a, Yu-Hsiang Shuc, Gary W. Chiend, XuFeng Chene, Feng Shie, Kimberly D. Siegmund b, Stephen K. Van Den Eedenf, Jiaoti Huange, and Chun R. Chao a,g  \naDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA; bDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; cBiostatistics and Innovations, Biostatistics and Programming, Clinical Affairs, Inari Medical, CA, USA; dDepartment of Urology, Los Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles, CA, USA; e Department of Pathology, Duke University School of Medicine, Durham, NC, USA; fDivision of Research, Kaiser Permanente Northern California, Oakland, CA, USA; gDepartment of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA, USA  \nABSTRACT  \nAccurately identifying life-threatening prostate cancer (PCa) at time of diagnosis remains an unsolved problem. We evaluated whether DNA methylation status of selected candidate genes can predict the risk of metastasis beyond clinical risk factors in men with untreated PCa. A nested case-control study was conducted among men diagnosed with localized PCa at Kaiser Permanente California between 01/01/1997–12/31/2006 who did not receive curative treatments. Cases were those who developed metastasis within 10 years from diagnosis. Controls were selected using density sampling. Ninety-eight candidate genes were selected from functional categories of cell cycle control, metastasis/tumour suppressors, cell signalling, cell adhesion/ motility/invasion, angiogenesis, and immune function, and 41 from pluripotency genes. Cancer DNA from diagnostic biopsy blocks were extracted and analysed. Associations of methylation status were assessed using CpG site level and principal components-based analysis in conditional logistic regressions. In 215 cases and 404 controls, 27 candidate genes were found to be statistically significant in at least one of the two analytical approaches. The agreement between the methods was 25.9%(7 candidate genes, including 2 pluripotency markers) . The DNA methylation status of several candidate genes was significantly associated with risk of metastasis in untreated localized PCa patients. These findings may inform future risk prediction models for PCa metastasis beyond clinical characteristics.  \nARTICLE HISTORY  \nReceived 26 July 2023 Revised 9 January 2024 Accepted 14 January 2024  \nKEYWORDS  \nProstate cancer; DNA methylation; metastasis  \nIntroduction  \nProstate cancer (PCa) is the most common cancer in men in the United States [ 1] . Approximately 80% of PCa cases are diagnosed at the localized stage, of which many are indolent and will not benefit from curative treatment [2,3] . Current clinical guidelines recommend active surveillance, rather than curative treatment, as the preferred care option for localized PCa patients with a“very low-risk profile”. Active surveillance can also be considered as a treatment option for other localized PCa[4] . However, a small proportion of localized PCa can progress to metastasis[5] .  \nAs such, there remains a need to identify PCa cases whose metastasis may be prevented by curative treatments at the localized stage. To this end, biomarkers that are closely related to tumour biology may help with the development of risk stratification algorithms for localized PCa and may also help inform the development of novel therapeutic targets.  \nEpigenetic regulation is a major mechanism underlying tumour heterogeneity and disease progression [6,7] . Of all epigenetic regulation mechanisms, DNA methylation is the most stable and readily measurable for use as a clinical  \nCONTACT Chun R. Chao  [chun.r.chao@kp.org](chun.r.chao@kp.org)  ","cbCaifos1UK8Wf2N","https://ap.wps.com/l/cbCaifos1UK8Wf2N","pdf",762399,13,"English","# Abstract\n# Introduction\n## Localized prostate cancer and clinical management\n## Need for biomarkers\n## Epigenetic regulation and DNA methylation","[{\"question\":\"What was the study goal regarding DNA methylation and metastasis?\",\"answer\":\"To determine whether DNA methylation status of selected candidate genes could predict metastasis risk beyond clinical risk factors in men with untreated localized prostate cancer.\"},{\"question\":\"How were cases and controls defined in the nested case-control design?\",\"answer\":\"Cases were men who developed metastasis within 10 years from diagnosis. Controls were selected using density sampling among men diagnosed with localized prostate cancer who did not receive curative treatments.\"},{\"question\":\"How many candidate genes were analyzed and what were the key findings?\",\"answer\":\"Ninety-eight candidate genes from metastasis- and biology-related functional categories plus 41 pluripotency genes were analyzed. In 215 cases and 404 controls, 27 genes showed statistically significant associations with metastasis risk in at least one analytical approach.\"}]","DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer | PDF",1790019766,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b056d7a15038d310e38213096074030.webp",983,1280,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6056d89138ab89c4e2811cdfedc8f09e.webp",982,1278,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/374c5b6708918a07a3acfd1cab421aac.webp",981,1277,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/663e631950dd7d5ba9f5f829dd126af6.webp",980,1276]